Company intelligence

GRI

GRI Bio, Inc. · NASDAQ · Healthcare

Price$1.94+0.52% · +$0.01

Market cap174.27KEquity value

P / E-0.0Trailing ratio

Volume260.48KLatest session

Market data

GRI price chart

TradingView

Related signals

1 min delayed

Browse public GRI signals with their source context and measured market impact. Open any signal for its permanent analysis page.

GRIApr 1, 2025-43.96% since signal

Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?

GRI Bio reported strong interim safety results for GRI-0621 in IPF treatment. GRI stock surged 95.9%, reaching $6.27 on high trading volume. Safety analysis showed GRI-0621 was well-tolerated in early patients. No significant cholesterol changes were observed, supporting safety profile. Topline results for Phase 2a study are expected in Q3 2025.

View signal analysis

Research